We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$74.8B
AUM Growth
+$3.67B
(+5.2%)
Cap. Flow
-$3.17B
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
28.58%
Holding
1,306
New
90
Increased
503
Reduced
491
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$534M |
| 2 |
Progressive
PGR
|
+$448M |
| 3 |
Workday
WDAY
|
+$394M |
| 4 |
KLA
KLAC
|
+$375M |
| 5 |
Airbnb
ABNB
|
+$310M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$814M |
| 2 |
Adobe
ADBE
|
+$648M |
| 3 |
NVIDIA
NVDA
|
+$583M |
| 4 |
Analog Devices
ADI
|
+$466M |
| 5 |
Nike
NKE
|
+$457M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.33% |
| 2 | Financials | 16.55% |
| 3 | Healthcare | 13.75% |
| 4 | Industrials | 9.51% |
| 5 | Consumer Discretionary | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Intensity Therapeutics
INTS
$12M
| $819K | ﹤0.01% |
+6,301
| New | +$755K |
|
827
Ocular Therapeutix
OCUL
$1.86B
| $819K | ﹤0.01% |
90,000
| – | – |
|
828
Quest Diagnostics
DGX
$25.1B
| $818K | ﹤0.01% |
6,149
-280
| -4% | -$36.3K |
|
829
iShares Residential and Multisector Real Estate ETF
REZ
$914M
| $809K | ﹤0.01% |
11,229
+8
| +0.1% | +$564 |
|
830
Healthpeak Properties
DOC
$15.4B
| $808K | ﹤0.01% |
43,117
+837
| +2% | +$15.2K |
|
831
Steel Dynamics
STLD
$35.6B
| $802K | ﹤0.01% |
5,408
+296
| +6% | +$37.2K |
|
832
Zscaler
ZS
$23B
| $800K | ﹤0.01% |
4,153
+641
| +18% | +$143K |
|
833
Moderna
MRNA
$21.5B
| $794K | ﹤0.01% |
7,450
+1,687
| +29% | +$170K |
|
|
RMT
834
Royce Micro-Cap Trust
RMT
$736M
| $791K | ﹤0.01% |
83,699
| – | – |
|
835
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.11B
| $788K | ﹤0.01% |
20,074
| – | – |
|
836
Sony
SONY
$123B
| $784K | ﹤0.01% |
45,705
-2,480
| -5% | -$45.6K |
|
837
MongoDB
MDB
$24B
| $783K | ﹤0.01% |
2,184
+42
| +2% | +$17.2K |
|
838
State Street Utilities Select Sector SPDR ETF
XLU
$23.8B
| $769K | ﹤0.01% |
23,442
-4,692
| -17% | -$146K |
|
839
Sprouts Farmers Market
SFM
$7.04B
| $769K | ﹤0.01% |
11,933
-56,391
| -83% | -$3.14M |
|
840
Humana
HUM
$46.7B
| $768K | ﹤0.01% |
2,215
-509
| -19% | -$193K |
|
841
Tractor Supply
TSCO
$16.3B
| $764K | ﹤0.01% |
14,590
+265
| +2% | +$12.7K |
|
842
Lincoln National
LNC
$7.91B
| $763K | ﹤0.01% |
23,910
+10,146
| +74% | +$280K |
|
843
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.68B
| $760K | ﹤0.01% |
7,528
| – | – |
|
844
Acuity Brands
AYI
$9.88B
| $751K | ﹤0.01% |
2,793
+312
| +13% | +$75.6K |
|
845
Manhattan Associates
MANH
$8.97B
| $749K | ﹤0.01% |
2,993
+1,696
| +131% | +$404K |
|
846
iShares S&P Small-Cap 600 Value ETF
IJS
$8.11B
| $748K | ﹤0.01% |
7,282
-923
| -11% | -$91.6K |
|
847
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.4B
| $747K | ﹤0.01% |
12,981
+5,638
| +77% | +$314K |
|
848
Invesco S&P 500 Top 50 ETF
XLG
$10.5B
| $743K | ﹤0.01% |
+17,631
| New | +$709K |
|
|
FITB
849
Fifth Third Bancorp
FITB
$52B
| $741K | ﹤0.01% |
19,912
-12,391
| -38% | -$431K |
|
850
First Horizon
FHN
$12.1B
| $740K | ﹤0.01% |
48,030
+152
| +0.3% | +$2.18K |
|
Similar funds
QCM
Brown Advisory's Q1 2024 Portfolio in Review
As of Q1 2024, Brown Advisory held 1,306 positions worth $74.8B, up 5.2% from $71.1B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory withdrew a net $3.17B in Q1 2024, closing 63 positions and reducing 491 holdings. Its most notable exit was Karuna Therapeutics, Inc. Common Stock, an estimated $105M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Brown Advisory opened a new position in Amer Sports worth $85M.
- Brown Advisory's largest Q1 2024 buy was Amer Sports: 5,215,063 shares worth $85M.
- Brown Advisory added most to KKR & Co in Q1 2024, an estimated $534M increase.
- Brown Advisory's biggest Q1 2024 reduction was UnitedHealth, cutting an estimated $814M.
- Brown Advisory fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $105M.
- Brown Advisory's ten largest holdings make up 29% of its $74.8B portfolio in Q1 2024.
- Brown Advisory opened 90 new positions and closed 63 in Q1 2024.
- Brown Advisory's portfolio value rose 5.2% quarter-over-quarter to $74.8B.
Based on Brown Advisory's 13F filing for Q1 2024, filed 24 Apr 2024.